username: password:     Join free | Forgot password
Add to favorites    中文
home > news and events
Share a snowman with OGT to win an Amazon Kindle Fire tablet

Clicks:644 Date:12/13/12
Build and dress a snowman with OGT鈥檚 interactive Share-a-Snowman Game
Oxford, UK 鈥 12 December 2012. Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, invites you to get into the spirit of sharing this holiday season with its interactive Share-a-Snowman Game. In true festive style, OGT has once again decided to send an electronic Christmas card and will be making a donation to a number of charities in lieu of sending paper cards. The e-card will feature the snowman builder game; create your own snowman and send it to your friends and colleagues. Who can be the most original? Plus you can submit your creation to OGT鈥檚 snowman gallery for a chance to win an Amazon Kindle Fire tablet for the best-dressed snowman! Visit the company鈥檚 user-friendly and highly informative website to find out more about OGT鈥檚 innovative genomic services, clinical genetics products and diagnostic biomarker programmes. For more information about the charities supported by OGT, including how to make a donation, please visit OGT鈥檚 social responsibility page.

Build and dress a snowman with OGT鈥檚 interactive Share-a-Snowman Game

For further information, please contact:
Oxford Gene Technology, Begbroke Science Park, Begbroke Hill, Woodstock Road, Begbroke, Oxfordshire, OX5 1PF, U.K.
T: +44 (0) 1865 856826 ; F: +44 (0) 1865 848684 ; E:
About Oxford Gene Technology
Founded by Professor Ed Southern, Oxford Gene Technology (OGT) provides innovative clinical genetics and diagnostic solutions to advance molecular medicine.
Diagnostic Biomarkers: Utilising proprietary next generation technologies, OGT is building a rich patent-protected portfolio of promising biomarkers for early-stage cancer and autoimmune disease detection. The biomarker pipeline includes advanced programmes in colorectal cancer, prostate cancer and pancreatic cancer plus the autoimmune disease systemic lupus erythematosus (SLE). OGT is currently assessing partnership opportunities to commercialise these biomarker panels.
Clinical & Genomic Solutions: OGT鈥檚 Genefficiency™ is a unique combination of world-leading platforms, people, processing power and performance synchronised to deliver rapid, high-quality genomic data to customers worldwide. OGT鈥檚 CytoSure™ cytogenetics array, labelling and interpretation software products and services provide a complete solution for the detection of chromosomal abnormalities. Together, Genefficiency and CytoSure offer a unique, standardised and integrated solution for cytogenetics research.
CytoSure: For research use only
This product is provided under an agreement between Agilent Technologies, Inc., and OGT. The manufacture, use, sale or import of this product may be subject to one or more of U.S. patents, pending applications, and corresponding international equivalents, owned by Agilent Technologies, Inc. The purchaser has the non-transferable right to use and consume the product for RESEARCH USE ONLY AND NOT for DIAGNOSTICS PROCEDURES. It is not intended for use, and should not be used, for the diagnosis, prevention, monitoring, treatment or alleviation of any disease or condition, or for the investigation of any physiological process, in any identifiable human, or for any other medical purpose.
Related News>> more

Copyright(C) 2006-2015 bio-equip   娌狪CP澶06040519鍙